Rexahn Pharmaceuticals, Inc. (RNN) Reports Third Quarter Financial Results And Pipeline Update
11/14/2013 9:58:25 AM
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer is providing a quarterly update today on its three clinical development programs and financial results.
Help employers find you! Check out all the jobs and post your resume.
comments powered by